摘要
背景:寄生虫感染如利什曼病是一种被忽视的热带病,是一个重大的全球负担,造成高死亡率,特别是在欠发达国家。其细胞内的性质和寄生虫的传播位置,有限数量的化学治疗剂,对一线药物和毒性的抵抗力的增加的发生率,对通过调节现有药物的传递而必须有效管理利什曼原虫感染的科学家构成了巨大的挑战。在过去十年中,已经广泛研究了基于纳米技术的药物递送系统(纳米颗粒,纳米悬浮液,脂质体等)等替代疗法的开发研究,天然产物的使用以及开发抗风险疫苗的研究。 目的:本次审查的重点是治疗策略,现有的杂项药物递送系统和旨在管理的方法以及感染治疗的不同方面,目的是总结当前系统地采用的治疗策略趋势和策略。此外,该文章还包含了一系列专利专利,涉及用于抗风湿疗法的新型化疗药物。 结论:报告的杂项新型药物递送系统以及各种方法似乎是精确,安全和相对有效的;在结果中,可能导致利什曼病治疗的新轨迹。
关键词: 利什曼病,治疗策略,纳米载体,纳米颗粒,脂质体,疫苗,天然产物,专利。
图形摘要
Current Drug Targets
Title:Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis
Volume: 18 Issue: 14
关键词: 利什曼病,治疗策略,纳米载体,纳米颗粒,脂质体,疫苗,天然产物,专利。
摘要: Background: Parasitic infection such as leishmaniasis, a neglected tropical disease, presents a significant global burden which is responsible for high mortality rate especially in less developed countries. Its intracellular nature and disseminated locations of parasite, limited number of chemotherapeutic agents, increasing incidences of resistance to first line drugs and toxicities, pose a great challenge to formulation scientists that have necessitated effective management of leishmanial infection by modulating the delivery of existing drugs. Over the past decade, research on development of alternative treatments such as nanotechnology-based drug delivery systems (nanoparticles, nanosuspensions, liposomes etc.), use of natural products as well as development of antileishmanial vaccine has been extensively investigated.
Objective: The present review focuses on different facets of therapeutic strategies, existing miscellaneous drug delivery systems and approaches intended for management, as well as treatment of the infection, with an objective to summarize the current trends and strategies adopted for antileishmanial therapy in a systematic manner. Moreover, the article encloses an eclectic collection of patents allied to new-fangled chemotherapeutics for antileishmanial therapy.
Conclusion: The reported miscellaneous novel drug delivery systems along with the diverse approaches are seem to be precise, secure and relatively effective; and in an outcome, could lead to the new track for management of leishmaniasis.
Export Options
About this article
Cite this article as:
Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis, Current Drug Targets 2017; 18 (14) . https://dx.doi.org/10.2174/1389450117666160401124133
DOI https://dx.doi.org/10.2174/1389450117666160401124133 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review
Current Pharmaceutical Design Novel Approaches for Allergy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Current Hypertension Reviews Persistence of Trypanosoma cruzi in Experimental Chagasic Cardiomyopathy
Anti-Infective Agents Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Chronic Complications of Diabetes Mellitus: A Mini Review
Current Diabetes Reviews Potential Therapeutic Effects of Na+/Ca2+ Exchanger Inhibition in Cardiac Diseases
Current Medicinal Chemistry Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis
Current Vascular Pharmacology Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety Experimental Antioxidant Biotherapy for Protection of the Vascular Wall by Modified Forms of Superoxide Dismutase and Catalase
Current Pharmaceutical Design A Ligand-Based Virtual Screening Approach to Identify Small Molecules as hERG Channel Activators
Combinatorial Chemistry & High Throughput Screening Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
Current Medicinal Chemistry Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Mitochondrial Trifunctional Protein Defects: Molecular Basis and Novel Therapeutic Approaches
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Diagnoses of Gastrointestinal Cancers After Gastrointestinal Bleeding in Patients Receiving Clopidogrel or Warfarin
Current Drug Safety Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology Development of Novel Cardiovascular Therapeutics From Small Regulatory RNA Molecules - An Outline of Key Requirements
Current Pharmaceutical Design The Control of Arterial Hypertension: Epidemiological and Economic Challenge
Current Hypertension Reviews